Persistent URL of this record https://hdl.handle.net/1887/102625
In Collections
This item can be found in the following collections:
![An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours
- All authors
- Schoffski, P.; Adkins, D.; Blay, J.Y.; Gil, T.; Elias, A.D.; Rutkowski, P.; Pennock, G.K.; Youssoufian, H.; Gelderblom, H.; Willey, R.; Grebennik, D.O.
- Date
- 2013-10-31
- Journal
- European Journal of Cancer
- Volume
- 49
- Issue
- 15
- Pages
- 3219 - 3228